Zymeworks Inc. (NASDAQ: ZYME) completed its acquisition of Theravance Biopharma on Sept. 23, 2026, making Theravance Biopharma a part of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions